These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1730420)

  • 21. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
    Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
    Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
    Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
    Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early stage ovarian carcinoma--diagnosis and treatment].
    Abeler VM; Tropé CG
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):476-8. PubMed ID: 10833940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular seminoma: clinical significance of nuclear deoxyribonucleic acid ploidy pattern as studied by flow cytometry.
    Mor Y; Leibovich I; Raviv G; Nass D; Medalia O; Goldwasser B; Nativ O
    J Urol; 1995 Sep; 154(3):1041-3; discussion 1044. PubMed ID: 7637050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Karlsson M; Seidal T
    Int J Oncol; 2001 Dec; 19(6):1295-302. PubMed ID: 11713603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
    Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
    Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
    Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
    Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of cellular DNA content in ovarian cancer.
    Hamaguchi K; Nishimura H; Miyoshi T; Miyahara K; Tateno N; Yakushiji M; Yokoyama MM
    Gynecol Oncol; 1990 May; 37(2):219-23. PubMed ID: 2344967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
    Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
    Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Flow cytometric analysis of DNA content in testicular seminomas--correlation to mitotic count].
    Kashiwagi A; Nagamori S; Nonomura K; Toyota K; Koyanagi T; Nojima T; Inoue K
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):239-45. PubMed ID: 2041270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytofluorometric analysis of the DNA content in ovarian carcinoma and its relationship to patient survival.
    Murray K; Hopwood L; Volk D; Wilson JF
    Cancer; 1989 Jun; 63(12):2456-60. PubMed ID: 2720595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometry.
    Wagner TM; Adler A; Sevelda P; Assmann I; Knepflé CF; Czerwenka K; Heinzl H; Ploem-Zaaijer JJ
    Int J Cancer; 1994 Jan; 56(2):167-72. PubMed ID: 8314296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DNA content of ovarian tumors: correlation to established prognostic parameters and clinical course].
    Kristen P; Kaesemann H; Dostert M; Caffier H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():204-5. PubMed ID: 8118271
    [No Abstract]   [Full Text] [Related]  

  • 39. Ovarian dysgerminoma. A clinico-pathologic study.
    Resta L; Sabatini R; Restaino A
    Neoplasma; 1984; 31(4):459-64. PubMed ID: 6472517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.